Previous studies have also uncovered that E2F-1 transcriptionally activates ATM, which is the main cellular sensor of DNA damage, representing a potential therapeutic tool for DDP resistance [55], indicating that E2F-1 may affect the sensitivity of DDP-resistant NPC cells to DDP via positive regulation of ATM. Here, E2F1 is linked to nasopharyngeal carcinoma.